Adenomatous polyposis coli alteration in digestive endocrine tumours: Correlation with nuclear translocation of β-catenin and chromosomal instability

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 1013-1024

  Pizzi, Silvia ^a   Azzoni, Cinzia ^a   Tamburini, Elisa ^a   Bottarelli, Lorena ^a   Campanini, Nicoletta ^a   D'Adda, Tiziana ^a   Fellegara, Giovanni ^a   Luong, Tu Vinh ^a   Pasquali, Claudio ^b   Rossi, Giulio ^c   Delle Fave, Gianfranco ^d   Camisa, Roberta ^e   Bordi, Cesare ^a   Rindi, Guido ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME TRANSLOCATION; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DIGESTIVE SYSTEM CANCER; DUODENUM CARCINOMA; ENDOCRINE TUMOR; FEMALE; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOMA;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CYTOPLASM; DNA METHYLATION; ENDOCRINE GLAND NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; WNT PROTEINS; YOUNG ADULT;

EID: 58249110608     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0230     Document Type: Article

References (37)

1. Arnold CN, Sosnowski A & Blum HE 2004a Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system. Annals of the New York Academy of Sciences 1014 218-219.
2. Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM & Boland CR 2004b APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biology and Theraphy 3 960-964.
3. Aust DE, Terdiman JP, Willenbucher RF, Chew K, Ferrell L, Florendo C, Molinaro-Clark A, Baretton GB, Lohrs U & Waldman FM 2001 Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Modern Pathology 14 29-39.
4. Barshack I, Goldberg I, Chowers Y, Horowitz A & Kopolovic J 2002 Different beta-catenin immunoexpression in carcinoid tumors of the appendix in comparison to other gastrointestinal carcinoid tumors. Pathology, Research and Practice 198 531-536.
5. Bordi C, Yu JY, Baggi MT, Davoli C, Pilato FP, Baruzzi G, Gardini G, Zamboni G, Franzin G, Papotti M et al. 1991 Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer 67 663-672.
6. Bright Thomas RM & Hargest R 2003 APC, beta-catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer. European Journal of Surgical Oncology 29 107-117.
7. D'Adda T, Keller G, Bordi C & Holler H 1999a Loss of heterozygosity at 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Laboratory Investigation 79 671-677.
8. D'Adda T, Candidus S, Denk H, Bordi C & Hoefler H 1999b Gastric neuroendocrine neoplasms: tumour clonality and matignancy-associated large X-chromosomal deletions. Journal of Pathology 189 394-401.
9. D'Adda T, Pizzi S, Azzoni C, Bottarelli L, Crafa P, Pasquali C, Davoli C, Corleto VD, Delle Fave G & Bordi C 2002 Different patterns of 11q allelic losses in digestive endocrine tumors. Human Pathology 33 322-329.
10. Doglioni C, Piccinin S, Demontis S, Cangi MG, Pecciarini L, Chiarelli C, Armellin M, Vukosavljevic T, Boiocchi M & Maestro R 2003 Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation. American Journal of Pathology 163 2277-2287.
11. Doucas H, Garcea G, Neal CP, Manson MM & Berry DP 2005 Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. European Journal of Cancer 41 365-379.
12. Fujimori M, Ikeda S, Shimizu Y, Okajima M & Asahara T 2001 Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Research 61 6656-6659.
13. Gerdes B, Ramaswamy A, Simon B, Pietsch T, Bastian D, Kersting M, Moll R & Bartsch D 1999 Analysis of beta-catenin gene mutations in pancreatic tumors. Digestion 60 544-548.
14. Hanson CA & Miller JR 2005 Non-traditional roles for the adenomatous polyposis coli (APQ tumor suppressor protein. Gene 361 1-12.
15. Herman JG, Graff JR, Myohanen S, Nelkin B & Baylin SB 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. PNAS 93 9821-9826.
16. Hervieu V, Lepinasse F, Gouysse G, Guillaud O, Barel C, Chambonniere ML, Bringuier PP, Poncet G, Lombard-Bohas C, Partensky C et al. 2006 Expression of beta-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases. Journal of Clinical Pathology 59 1300-1304.
17. House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A & Yeo CJ 2003 Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Annals of Surgery 238 423-431.
18. Jonkers YM, Claessen SM, Perren A, Schmitt AM, Hofland LJ, de Herder W, de Krijger RR, Verhofstad AA, Hermus AR, Kummer JA et al. 2007 DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine-Related Cancer 14 769-779.
19. Kaplan E & Meier P 1958 Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53 457-481.
20. Kikuchi A 2003 Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Science 94 225-229.
21. Li CC, Xu B, Hirokawa M, Qian ZR, Yoshimoto K, Horiguchi H, Tashiro T & Sano T 2002 Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract. Virchows Archiv 440 145-154.
22. Mantel N 1966 Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 50 163-170.
23. Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G et al. 1992 Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. PNAS 89 4452-4456.
24. Pizzi S, D'Adda T, Azzoni C, Rindi G, Grigolato P, Pasquali C, Corleto VD, Delle Fave G & Bordi C 2002 Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine turnours. Journal of Pathology 196 401-407.
25. Pizzi S, Azzoni C, Bassi D, Bottarelli L, Milione M & Bordi C 2003 Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 98 1273-1282.
26. Pizzi S, Azzoni C, Bottarelli L, Campanini N, D'Adda T, Pasquali C, Rossi G, Rindi G & Bordi C 2005 RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. Journal of Pathology 206 409-416.
27. Rindi G & Bordi C 2003 Highlights of the biology of endocrine tumours of the gut and pancreas. Endocrine-Related Cancer 10 427-436.
28. Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P et al. 2006 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 449 395-401.
29. Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A et al. 2007 TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 451 757-762.
30. Saito T, Oda Y, Sakamoto A, Kawaguchi K, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y & Tsuneyoshi M 2002 APC mutations in synovial sarcoma. Journal of Pathology 196 445-449.
31. Sakai Y, Koizumi K, Sugitani I, Nakagawa K, Arai M, Utsunomiya J, Muto T, Fujita R & Kato Y 2002 Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses. American Journal of Surgical Pathology 26 103-110.
32. Samowitz WS, Powers MD, Spirio LN, Nollet F, van Roy F & Slattery ML 1999 Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Research 59 1442-1444.
33. Semba S, Kusumi R, Moriya T & Sasano H 2000 Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocrine Pathology 11 243-250.
34. Solcia E, Capella C, Klöppel G, Heitz PU, Sobin LH & Rosai J 2000 Endocrine tumours of the gastrointestinal tract. In Histological Typing of Endocrine Tumours, edn 2, pp. 61-68. Eds E Solcia, G Klöppel LH & Sobin. Berlin: Springer.
35. Su MC, Wang CC, Chen CC, Hu RH, Wang TH, Kao HL, Jeng YM & Yuan RH 2006 Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor. Annals of Surgical Oncology 13 1604-1609.
36. Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S et al. 2000 Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19 3642-3646.
37. Zauber NP, Sabbath-Solitare M, Marotta SP & Bishop DT 2003 The adenomatous polyposis coli (APQ gene microsatellite marker D5S1385 is equally informative for loss of heterozygosity as the marker D5S346. Experimental and Molecular Pathology 75 144-147.